Zymosense

Zymosense

Private
Ames, IowaHealthcare & Life Scienceshttps://zymosense.com/

Last Round

Grant

Nov 17, 2023

Total Funding Raised

$750,000

Company Overview

Zymosense is a nanotechnology company that has developed an enzyme screening platform to identify and characterize enzymes. The company's products use fluorescent nanoparticles suspended in target enzyme substrates to produce activity probes, enabling research scientists to access rapid evaluation, discovery, and design of new enzymes.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Sensors, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

enzyme activity measurementenzyme assaynanosensor platformsingle-walled carbon nanotubesSWCNTslabel-free assaybiotechnology toolsoptical nanosensorsreal-time measurementcustom assay developmentenzyme discoverynear-infrared detectiondrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zymosense Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Zymosense Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantNov 17, 2023
DebtJun 13, 2023
GrantSep 20, 2022
DebtJul 22, 2022
GrantDec 7, 2021
Grant
Dec 1, 2021

Key People

Founding team and executive leadership

Scott Nelson

Chief Executive Officer

Executive Team

Nathaniel Kallmyer

Chief Technology Officer

Executive Team

Zymosense Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 17, 2023

    $75K grant from America's Seed Fund and Iowa Economic Development Authority.

  • Jun 13, 2023

    $100K round from Iowa Economic Development Authority

Zymosense Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zymosense Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zymosense's valuation, stock price, and market status.

Firmographic Details

HeadquartersAmes, Iowa
Employee Range4
Year Founded2021
Last FundingNov 17, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.